The prevalence and risk factors of microalbuminuria in normoglycemic, normotensive adults

Clinical Nephrology

Volumn 65, Issue 4, 2006, Pages 256-261

  Choi, H S ^a   Sung, K C ^a   Lee, Kyu Beck ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Microalbuminuria; Normoglycemic; Normotensive adults

Indexed keywords

C REACTIVE PROTEIN;

ADULT; ANALYSIS OF VARIANCE; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHINA; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GLUCOSE BLOOD LEVEL; HEALTH SURVEY; HOMEOSTASIS; HUMAN; HYPERTENSION; INSULIN RESISTANCE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; MICROALBUMINURIA; PREVALENCE; REFERENCE VALUE; RISK ASSESSMENT; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; URINALYSIS;

EID: 33645755855     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/CNP65256     Document Type: Article

References (19)

1. Barzilay JI, Peterson D, Cushman M, Heckbert SR, Cao JJ, Blaum C, Tracy RP, Klein R, Herrington DM. The relationship of cardiovascular risk factors to microalbuminuria in older adults with or without diabetes mellitus or hypertension: the cardiovascular health study. Am J Kidney Dis. 2004; 44: 25-34.
2. Bennett PH, Haffner S, Kasiske BL, Keane WF, Mogensen CE, Parving HH, Steffes MW, Striker GE. Screening and management of microalbuminuria in patients with diabetes mellitus: Recommendations to the Scientific Advisory Board of the National Kidney Foundation from an ad hoc committee of the Council on Diabetes Mellitus of the National Kidney Foundation. Am J Kidney Dis. 1995; 25: 107-112.
3. Bravata DM, Wells CK, Concato J, Kernan WN, Brass LM, Gulanski BI. Two measures of insulin sensitivity provided similar information in a U.S. population. J Clin Epidemiol. 2004; 57: 1214-1217.
4. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ. National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report. JAMA. 2003; 289: 2560-2572.
5. Gansevoort RT, Verhave JC, Hillege HL, Burgerhof JG, Bakker SJ, de Zeeuw D, de Jong PE; for the PREVEND Study Group. The validity of screening based on spot morning urine samples to detect subjects with microalbuminuria in the general population. Kidney Int. 2005; 94 (Suppl): S28-35.
6. Gerstein HC, Mann JF Yi Q, Zinman B, Dinneen SF, Hoogwerf B, Halle JP, Young J, Rashkow A, Joyce C, Nawaz S, Yusuf S; HOPE Study Investigators. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA. 2001; 286: 421-426.
7. Hillege HL, Janssen WM, Bak AA, Diercks GF, Grobbee DE, Crijns HJ, Van Gilst WH, De Zeeuw D, De Jong PE; PREVEND Study Group. Microalbuminuria is common, also in a nondiabetic, nonhypertensive population, and an independent indicator of cardiovascular risk factors and cardiovascular morbidity. J Intern Med. 2001; 249: 519-526.
8. Jones CA, Francis ME, Eberhardt MS, Chavers B, Coresh J, Engelgau M, Kusek JW, Byrd-Holt D, Narayan KM, Herman WH, Jones CP, Salive M, Agodoa LY. Microalbuminuria in the US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis. 2002; 39: 445-459.
9. Karalliedde J, Viberti G. Microalbuminuria and cardiovascular risk. Am J Hypertens. 2004; 17: 986-993.
10. Mann JF, Gerstein HC, Yi QL, Franke J, Lonn EM, Hoogwerf BJ, Rashkow A, Yusuf S; HOPE Investigators. Progression of renal insufficiency in type 2 diabetes with and without microalbuminuria: Results of the Heart Outcomes and Prevention Evaluation (HOPE) randomized study. Am J Kidney Dis. 2003; 42: 936-942.
11. Mattix HJ, HSU CY, Shaykevich S, Curhan G. Use of the albumin/creatinine ratio to detect microalbuminuria: Implication of sex and race. J Am Soc Nephrol. 2002; 13: 1034-1039.
12. Mogensen CE. Microalbuminuria and hypertension with focus on type 1 and type 2 diabetes. J Int Med. 2003; 254: 45-66.
13. Pontremoli R, Leoncini G, Ravera M, Hazzi F, Vettoretti S, Ratio E, Parodi D, Tomolillo C, Deferrari G. Microalbuminuria, cardiovascular, and renal risk in primary hypertension. J Am Soc Nephrol. 2002; 13: 169-172.
14. Romundstad S, Holmen J, Kvenild K, Hallan H, Ellekjaer H. Microalbuminuria and all-cause mortality in 2,089 apparently healthy individuals: A 4.4-year follow-up study. The Nord-Trondelag Health Study (HUNT), Norway. Am J Kidney Dis. 2003; 42: 466-473.
15. Russo LM, Bakris GL, Comper WD. Renal handling of albumin: A critical review of basic concepts and perspective. Am J Kidney Dis. 2002; 39: 899-919.
16. Russo LM, Comper WD, Osicka TM. Mechanism of albuminuria associated with cardiovascular disease and kidney disease. Kidney Int. 2004; 92 (Suppl): S67-68.
17. Stehouwer CD, Gall MA, Twisk JW, Knudsen E, Emeis JJ, Parving HH. Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes: Progressive, interrelated, and independently associated with risk of death. Diabetes. 2002; 51: 1157-1165.
18. Stern SE, Williams K, Ferrannini E, DeFronzo RA, Bogardus C, Stern MP. Identification of individuals with insulin resistance using routine clinical measurements. Diabetes. 2005; 54: 333-339.
19. Young BA, Katon WJ, Von Korff M, Simon GE, Lin EH, Ciechanowski PS, Bush T, Oliver M, Ludman EJ, Boyko EJ. Racial and ethnic differences in microalbuminuria prevalence in a diabetes population: The pathways study. J Am Soc Nephrol. 2005; 16: 219-228.